Skip Navigation
Skip to contents



13 results

Sclerotheraphy with OK-432 for the Treatment of Lymphangiomas

Wang YG, Seo HI, Kim HY

  • Cancer Res Treat.
  • 2002 Feb;34(1):62-66.
PURPOSE: To evaluate the efficacy of sclerotherapy with OK-432 for lymphangiomas. MATERIALS AND METHODS: Retrospective review of twelve patients with lymphangiomas who were treated with OK-432 from 1996 to 2000. RESULTS: Twelve...
Conjunctival Lymphoma: Retrospective Analysis of the Treatment Result and Complications with Radiation Therapy

Kim KJ, Ahn SD, Choi EK, Chang H, Kim JH

  • Cancer Res Treat.
  • 2002 Feb;34(1):58-61.
PURPOSE: In order to evaluate the response to radiation therapy and to analyze the patterns of failure, survival and complications, we performed a retrospective analysis of patients with conjunctival lymphoma. MATERIALS...
Expression of Cell Surface Receptors on Human Glioblastoma Xenograft Model in NOD/SCID Mouse

Oh KS, Kim KU, Park NH, Seo SY, Choi SS, Huh GY

  • Cancer Res Treat.
  • 2002 Feb;34(1):52-57.
PURPOSE: To obtain basic data for development of a glioblastoma-specific immunotoxin, the expression of variable cell surface receptors on a human glioblastoma xenograft model was evaluated, using NOD/SCID mice. MATERIALS AND...
Telomerase Activity and Expression of hTR and TERT in Human Soft Tissue Sarcomas

Yoo J, Kang SJ, Kim BK

  • Cancer Res Treat.
  • 2002 Feb;34(1):46-51.
PURPOSE: Sarcomas have rarely been analyzed for telomerase, which is an RNA-dependent DNA polymerase to maintain telomeres and prevent telomere shortening. This study was undertaken to determine telomerase activity and...
Correlation of Mast Cell Densities, Angiogenesis and Vascular Endothelial Growth Factor in Proper Muscle Gastric Carcinomas

Nam ES, Kim DH, Jang GT, Park HR, Kim JR, Shin HS

  • Cancer Res Treat.
  • 2002 Feb;34(1):41-45.
PURPOSE: There are increasing evidences that angiogenesis enhances tumor growth and biological aggressiveness in gastric carcinoma. Mast cells have been implicated in the angiogenic process, by secreting angiogenic factors including...
Clinical Significance of p53, P-glycoprotein, and Glutathione S transferase-pi in Advanced Non-Small Cell Lung Cancer

Joo YD, Sohn CH

  • Cancer Res Treat.
  • 2002 Feb;34(1):34-40.
PURPOSE: A retrospective study was performed o define the clninical significance of p53, P-glycoprotein (Pgp), and Glutathione S transferase-pi (GST-pi) immunohistochemical (IHC) expression in advanced non-small cell lung cancer (NSCLC). MATERIALS...
Efficacy of Combination Chemotherapy with Paclitaxel and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Rhee EJ, Jeong HS, Lee SS

  • Cancer Res Treat.
  • 2002 Feb;34(1):28-33.
PURPOSE: To evaluate the efficacy and toxicity of the combination therapy of paclitaxel and cisplatin in advanced, non-small cell, lung cancer patients MATERIALS AND METHODS: Between December 1997 and September 2001,...
A Phase II Study with Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer

Park JW, Park HY, Park YB, Kang JW, Kim SH, Lee GL, Kim BS, Roh YH

  • Cancer Res Treat.
  • 2002 Feb;34(1):23-27.
PURPOSE: To evaluate the efficacy and safety of gemcitabine and carboplatin (GC) in the treatment of advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: Between November 1999 and April 2001, 34...
Loss of CD10/NEP Expression in the Pulmonary Carcinogenesis

Myoug N

  • Cancer Res Treat.
  • 2002 Feb;34(1):17-22.
PURPOSES: The cell surface metalloproteinase CD10/ neutral endopeptidase 24.11 (NEP) hydrolyzes a variety of peptide substrates and reduces cellular responses to specific peptide hormones. CD10/NEP has been recognized as modulating...
Lung Cancer Screening with Low-Dose Spiral CT

Ahn MI

  • Cancer Res Treat.
  • 2002 Feb;34(1):13-16.
No abstract available.
Genetic Susceptibility to Lung Cancer in Koreans

Park JY

  • Cancer Res Treat.
  • 2002 Feb;34(1):8-12.
No abstract available.
Epidemiology of Lung Cancer in Korea

Lee CT

  • Cancer Res Treat.
  • 2002 Feb;34(1):3-5.
No abstract available.
Lung Cancer in Korea

Kim HK

  • Cancer Res Treat.
  • 2002 Feb;34(1):1-2.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: